InsidersTradesSigma
Follow the CLARITY PHARMACEUTICALS LTD stock price and the full management transaction log of the company, a publicly traded company based in Australia. Shares are listed on the AU market, under the oversight of ASX. Market capitalisation: €1bn. Every trade is accessible without an account.
Analysts rate CLARITY PHARMACEUTICALS LTD Strong Buy (bullish), based on 4 analysts. Average price target: A$7.20.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
No declarations found
0 of 0 declarations
CLARITY PHARMACEUTICALS LTD is a company focused on developing innovative treatments for serious diseases. It is listed on the XASX market.